Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Huaier Extract Inhibits Prostate Cancer Growth via Targeting AR/AR-V7 Pathway
Zhengfang Liu, Cheng Liu, Keqiang Yan, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 18

Showing 18 citing articles:

The Crucial Role of AR-V7 in Enzalutamide-Resistance of Castration-Resistant Prostate Cancer
Zeyuan Zheng, Jinxin Li, Yankuo Liu, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4877-4877
Open Access | Times Cited: 39
Chinese herbal medicines for prostate cancer therapy: From experimental research to clinical practice
Fanming Kong, Chaoran Wang, Jing Zhang, et al.
Chinese Herbal Medicines (2023) Vol. 15, Iss. 4, pp. 485-495
Open Access | Times Cited: 23
A Comprehensive Overview of Small-Molecule Androgen Receptor Degraders: Recent Progress and Future Perspectives
Si Ha, Guoshun Luo, Hua Xiang
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 24, pp. 16128-16154
Closed Access | Times Cited: 24
Immunoregulatory effects of Huaier (Trametes robiniophila Murr) and relevant clinical applications
Hongrong Long, Zhongcai Wu
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Huaier suppresses cisplatin resistance in non-small cell lung cancer by inhibiting the JNK/JUN/IL-8 signaling pathway
Haoyi Jin, Changhao Liu, Xi Liu, et al.
Journal of Ethnopharmacology (2023) Vol. 319, pp. 117270-117270
Closed Access | Times Cited: 10
Marsdenia tenacissima (Roxb.) Moon injection exerts a potential anti-tumor effect in prostate cancer through inhibiting ErbB2-GSK3β-HIF1α signaling axis
Xin Chen, Zhuo Luo, Xi Liu, et al.
Journal of Ethnopharmacology (2022) Vol. 295, pp. 115381-115381
Closed Access | Times Cited: 16
Berberine enhances gemcitabine‑induced cytotoxicity in bladder cancer by downregulating Rad51 expression through inactivating the PI3K/Akt pathway
Xinghua Gao, Ji‐Kai Liu, Daming Fan, et al.
Oncology Reports (2021) Vol. 47, Iss. 2
Open Access | Times Cited: 17
Huaier Inhibits Gastric Cancer Growth and Hepatic Metastasis by Reducing Syntenin Expression and STAT3 Phosphorylation
Yunfu Shi, Yuan Li, Jingli Xu, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-14
Open Access | Times Cited: 10
The natural medicinal fungus Huaier promotes the anti-hepatoma efficacy of sorafenib through the mammalian target of rapamycin-mediated autophagic cell death
Zhengguang Zhang, Cunsi Shen, Fuqiong Zhou
Medical Oncology (2022) Vol. 39, Iss. 12
Closed Access | Times Cited: 9
Efficacy and Safety of Huaier Granule as an Adjuvant Therapy for Cancer: An Overview of Systematic Reviews and Meta-Analyses
Jixin Chen, Shuqi Chen, Yushu Zhou, et al.
Integrative Cancer Therapies (2022) Vol. 21
Open Access | Times Cited: 8
The Transmembrane Protein TM4SF3 Interacts With AR and AR-V7 and is Recruited to AR Target Genes
Prabesh Khatiwada, Ujjwal Rimal, Zhengyang Han, et al.
Endocrinology (2023) Vol. 164, Iss. 5
Closed Access | Times Cited: 4
Huaier promotes sensitivity of colorectal cancer to oxaliplatin by inhibiting METTL3 to regulate the Wnt/β‑catenin signaling pathway
Mingyi Huo, Zhixu Gao, Guizhen Wang, et al.
Oncology Reports (2024) Vol. 53, Iss. 1
Open Access | Times Cited: 1
The crosstalk between ubiquitination and endocrine therapy
Yidong Ge, Ziqing Zhan, Meng Ye, et al.
Journal of Molecular Medicine (2023) Vol. 101, Iss. 5, pp. 461-486
Closed Access | Times Cited: 2
A Critical Assessment for Hualer, A Traditional Chinese Medicine, for Cancer Therapy: Medicinal Characteristics, Molecular Mechanisms of Action, In-Vitro and In-Vivo Anticancer Activities, and Future Research Directions
Xinuo Zhang, Shengqiang Tong, Jiang‐Jiang Qin, et al.
Deleted Journal (2024) Vol. 2, Iss. 1, pp. 29-47
Open Access
Nutraceuticals target androgen receptor-splice variants (AR-SV) to manage castration resistant prostate cancer (CRPC)
Ashish Tyagi, Balaji Chandrasekaran, Vaibhav Shukla, et al.
Pharmacology & Therapeutics (2024) Vol. 264, pp. 108743-108743
Closed Access
Therapeutic targets and signaling pathways of active components of QiLing decoction against castration-resistant prostate cancer based on network pharmacology
Hongwen Cao, Dan Wang, Renjie Gao, et al.
PeerJ (2022) Vol. 10, pp. e13481-e13481
Open Access | Times Cited: 2
Peer Review #1 of "Therapeutic targets and signaling pathways of active components of QiLing decoction against castration-resistant prostate cancer based on network pharmacology (v0.1)"
Hongwen Cao, Dan Wang, Renjie Gao, et al.
(2022)
Open Access
Peer Review #2 of "Therapeutic targets and signaling pathways of active components of QiLing decoction against castration-resistant prostate cancer based on network pharmacology (v0.1)"
Hongwen Cao, Dan Wang, Renjie Gao, et al.
(2022)
Open Access
Page 1

Scroll to top